A note for UK readers

This page explains France’s system. Its licences, funding rules and prescribing criteria do not determine access in the UK.

Can any valid prescription qualify for reimbursement?

No. Reimbursable treatment has specific patient criteria, an authorised initial prescriber and an accompanying prescription form.

Separate the two prescribing routes

Assurance Maladie explains that doctors may prescribe within the marketing authorisation, but that does not automatically open reimbursement. The initial prescription for funded care must come from an eligible clinician involved in specialist obesity care.

Funding is restricted

The June 2026 pathway covers specified adults with an initial BMI of at least 40, or at least 35 with a qualifying severe weight-related condition, after the required nutritional management. The detailed criteria should be checked with the treating team.

Take the form to the pharmacy

The doctor completes the accompanying form and gives it to the patient. It must be presented with the prescription at dispensing. People already receiving treatment before the new pathway also need the appropriate assessment and documentation.

Read the change from a UK perspective

This is a French reimbursement pathway, not a new NHS entitlement. It demonstrates why a UK comparison should distinguish licensed use from funded access and explain referral conditions. French reimbursed patient payments are not equivalent to UK private-package prices.

Keep these four questions separate

Access

French prescription and documentation requirements

Funding

Restricted reimbursement pathway since 15 June 2026

Cost context

French reimbursement does not establish a UK price

Regulatory source

ANSM; EU authorisation framework

Compare health systems ↗
Follow the evidence

Sources & further reading

Sources checked . These links support the information above; they do not imply endorsement of this website.

  1. Assurance Maladie: adult obesity treatment and prescribing
  2. French Health Ministry: GLP-1 weight-management reimbursement
A note on this guide

Written for a UK audience by the Health Comparisons editorial team. This page is an information resource and has not been presented as a clinician’s personal recommendation. Discuss treatment decisions with your prescriber.

Read our editorial standards →